Goemaere, S, Vanderschueren, D, Kaufman, J, Reginster, J, Boutsen, Y, Poriau, S, ...
Dual energy X-ray absorptiometry (DXA) measurements from different manufacturers provide different bone mineral density (BMD) values and derived T-scores and Z-scores. These differences result partly...
Geusens, P, Malaise, M, De Clerck, L, Raeman, F, ...
OBJECTIVE: To compare the effects of continuous and intermittent celecoxib treatment in patients with knee or hip osteoarthritis in flare. METHODS: In this 24-week, prospective, randomised,...
Kaufman, J. M, Reginster, J. Y, Boutsen, Y, Poriau, S, ...
Dual energy X-ray absorptiometry (DXA) measurements from different manufacturers provide different bone mineral density (BMD) values and derived T-scores and Z-scores. These differences result partly...
Luyten, F. P., GEUSENS, Piet, Malaise, M., De Clerck, L., Westhovens, R., Raeman, F., ...
Objective: To compare the effects of continuous and intermittent celecoxib treatment in patients with knee or hip osteoarthritis in flare. Methods: In this 24-week, prospective, randomised,...
Luyten, F. P., GEUSENS, Piet, Malaise, M., De Clerck, L., Westhovens, R., Raeman, F., ...
Objective: To compare the effects of continuous and intermittent celecoxib treatment in patients with knee or hip osteoarthritis in flare. Methods: In this 24-week, prospective, randomised,...
Goemaere, S, Vanderschueren, D, Kaufman, JM, Reginster, Jean-Yves, Boutsen, Y, Poriau, S, ...
Dual energy X-ray absorptiometry (DXA) measurements from different manufacturers provide different bone mineral density (BMD) values and derived T-scores and Z-scores. These differences result partly...
Rabenda, Véronique, Burlet, N, Belaiche, Jacques, Raeman, F, Richy, F, Reginster, Jean-Yves
Objective: Our goal was to identify the magnitude of gastro-protective drugs (GPDs) co-prescription and the profile of patients who received GPD co-prescription, during nonsteroidal anti-inflammatory...
Rabenda, Véronique, Burlet, N, Ethgen, Olivier, Raeman, F, Belaiche, Jacques, Reginster, Jean-Yves
OBJECTIVES: To capture changes in the quality of life (QoL) occurring in patients with osteoarthritis (OA) during treatment with non-specific non-steroidal anti-inflammatory drugs (NSAIDs) and to...
Meunier, PJ, Roux, C, Seeman, E, Ortolani, S, Badurski, JE, Spector, TD, ...
BACKGROUND: Osteoporotic structural damage and bone fragility result from reduced bone formation and increased bone resorption. In a phase 2 clinical trial, strontium ranelate, an orally active drug...
Body, J J, Devogelaer, J P, Raeman, F, Rozenberg, S, ...
Osteoporosis is now considered as a major public health issue and a serious threat for the quality of life of elderly women. Several new compounds are currently marketed for the prevention and...
Devogelaer, J P, Raeman, F, Rozenberg, S, Body, J J, ...
Department Endocrinology, University of Ghent, Belgium.
Diagnostiek van osteoporose. (1997)
DEVOGELAER, J, REGINSTER, J, RAEMAN, F, WESTHOVENS, R, ROZENBERG, S, BODY, J, ...
Enumeration of T lymphocytes subsets in autoimmune disease using monoclonal antibodies.
Raeman, F, De Cock, W, De Beukelaar, T, De Cree, J, Verhaegen, H
The numbers of T lymphocytes, B lymphocytes, helper and suppressor T lymphocytes were measured in peripheral blood of patients with autoimmune disease (rheumatoid arthritis, erythema nodosum,...
Rabenda, V, Burlet, N, Ethgen, O, Raeman, F, Belaiche, J, Reginster, J
Objectives: To capture changes in the quality of life (QoL) occurring in patients with osteoarthritis (OA) during treatment with non-specific non-steroidal anti-inflammatory drugs (NSAIDs) and to...